Townson Sharon (CIK 1855689) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-07). Recent activity: Buy GLUE (6,000 shares), Sell GLUE (5,600 shares), Sell GLUE (400 shares), Buy GLUE (3,000 shares), Sell GLUE (3,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-07 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Scientific Officer | Buy | 6,000 | $36,840 |
| 2026-07-07 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Scientific Officer | Sell | 5,600 | $130,197 |
| 2026-07-07 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Scientific Officer | Sell | 400 | $9,652 |
| 2026-06-25 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Scientific Officer | Buy | 3,000 | $18,420 |
| 2026-06-25 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Scientific Officer | Sell | 3,000 | $60,000 |
| 2026-06-18 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Scientific Officer | Buy | 3,000 | $18,420 |
| 2026-06-18 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Scientific Officer | Sell | 3,000 | $57,000 |
| 2026-06-01 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Scientific Officer | Buy | 6,000 | $36,840 |
| 2026-06-01 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Scientific Officer | Sell | 6,000 | $119,220 |
| 2026-01-05 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Scientific Officer | Buy | 35,000 | $0 |
| 2026-01-05 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Scientific Officer | Sell | 3,155 | $47,861 |
Source: SEC Form 4 filings · as of 2026-07-07